Skip to content

LCTX - Lineage Cell Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchL

Lineage Cell Therapeutics Inc

LCTX · AMEX

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

L

LCTXLineage Cell Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $2.09
52-wk low: $1.00
Prev close: $1.59
Mkt cap: $278.2M
Fwd P/E: 30.7x
Beta: 1.55

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$29.4M

MI
Millennium
Israel Englander · Q2 2026 13F
$4.0M
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings landed in line with what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -246.6%
Forward P/E: 30.67
Market cap: $278M

Valuation

P/S21.26
P/B4.40

Quality

Operating margin-835.0%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: LCTX
Exchange: AMEX
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $278.20M
Beta: 1.55

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

21.3x

P/B

4.4x

Profit margin

-246.6%

Op margin

-835.0%

ROE

-60.1%

$1.8M

position

MW

Marshall Wace

Q2 2026 13F

$1.7M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for LCTX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.03+$0.00

-$0.03 expected

Next report

What the street expects next

EPS expected

-$0.04

-$0.04 to -$0.03

Revenue expected

$1.3M

5 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

0.01

Change in 30 days

ROE

-60.1%

ROA-17.0%

Growth

Beta1.55